(Q44356342)

2 December 2017

title

Folic acid treatment reduces elevated plasma levels of asymmetric dimethylarginine in hyperhomocysteinaemic subjects (English)

1 reference

2 December 2017

1 reference

4

Pål Aukrust

0 references

Kirsten B. Holven

1

object named as

Kirsten B Holven

1 reference

2 December 2017

Tor S Haugstad

2

1 reference

2 December 2017

Torbjørn Holm

3

1 reference

2 December 2017

Leiv Ose

5

1 reference

2 December 2017

Marit S Nenseter

6

1 reference

2 December 2017

publication date

1 March 2003

1 reference

British Journal of Nutrition

2 December 2017

published in

1 reference

2 December 2017

volume

89

1 reference

2 December 2017

issue

3

1 reference

2 December 2017

page(s)

359-363

1 reference

Elevation of asymmetrical dimethylarginine may mediate endothelial dysfunction during experimental hyperhomocyst(e)inaemia in humans

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1079%2FBJN2002779

An endogenous inhibitor of nitric oxide synthase regulates endothelial adhesiveness for monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN2002779

Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN2002779

Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in monkeys with hyperhomocyst(e)inemia or hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN2002779

Oral folate enhances endothelial function in hyperhomocysteinaemic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN2002779

Homocysteine impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN2002779

Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN2002779

Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN2002779

Homocysteine-respondent genes in vascular endothelial cells identified by differential display analysis. GRP78/BiP and novel genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN2002779

Effect of folic acid treatment on endothelium-dependent vasodilation and nitric oxide-derived end products in hyperhomocysteinemic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN2002779

The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN2002779

Elevated levels of plasma homocyst(e)ine and asymmetric dimethylarginine in elderly patients with stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN2002779

Folic acid improves arterial endothelial function in adults with hyperhomocystinemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN2002779

Hyperhomocyst(e)inemia is a risk factor for arterial endothelial dysfunction in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN2002779

Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN2002779

A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN2002779

Influence of Folic Acid on Postprandial Endothelial Dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN2002779

Rapid high-performance liquid chromatographic assay for total homocysteine levels in human serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN2002779

Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN2002779

Acute hyperhomocysteinaemia and endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN2002779

Hyperhomocysteinemia after an oral methionine load acutely impairs endothelial function in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN2002779

Asymmetrical dimethylarginine, an endogenous nitric oxide synthase inhibitor, in experimental hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN2002779

Elevation of an endogenous inhibitor of nitric oxide synthesis in experimental congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN2002779

Inhibition of growth and p21ras methylation in vascular endothelial cells by homocysteine but not cysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN2002779

21 January 2018

Identifiers

DOI

10.1079/BJN2002779

1 reference

2 December 2017

1 reference